Distribution of CCND1 A870G polymorphism in patients with advanced uterine cervical carcinoma.

doi:10.1007/s12253-010-9293-3

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Distribution of CCND1 A870G polymorphism in patients with advanced uterine cervical carcinoma.

Pathology oncology research : POR - 1 Mar 2011

Warchoł Teresa, Kruszyna Lukasz, Lianeri Margarita, Roszak Andrzej, Jagodziński Paweł P

Abstract excerpt

We examined the distribution of the CCND1 A870G (rs9344) polymorphic variant in patients with cervical cancer (n = 129) and healthy individuals (n = 288) in a sample of a Polish cohort. We showed that patients with advanced cervical cancer bearing the CCND1 A/A and A/G genotypes displayed a 1.811-fold increased risk of cervical cancer (95% CI = 1.150-2.852, p = 0.0098). We also found a significantly higher...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin D1

Share to Neoplasm Staging

Share to Polymerase Chain Reaction

Share to Polymorphism, Restriction Fragment Length

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Share to Uterine Cervical Neoplasms

Source

Open in PubMed

Identifiers

PMID: 20680537
DOI: 10.1007/s12253-010-9293-3

Genes

CCND1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Distribution of CCND1 A870G polymorphism in patients with advanced uterine cervical carcinoma.PMID 20680537Read ↗

Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies.Semantic proximity Read ↗

CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.Semantic proximity Read ↗

Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.Semantic proximity Read ↗

Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.Semantic proximity Read ↗

Association of CCND1 Gene c.870G>A Polymorphism with Breast Cancer Risk: A Case-ControlStudy and a Meta-Analysis.Semantic proximity Read ↗

The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.Semantic proximity Read ↗

Cyclin D1 polymorphism and the risk of endometrial cancer.Semantic proximity Read ↗

Genetic variant of CCND1: association with HPV-mediated cervical cancer in Indian population.Semantic proximity Read ↗

CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population.Semantic proximity Read ↗

CCND1 G870A polymorphism and risk for head and neck cancer: a meta-analysis.Semantic proximity Read ↗

Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.